ASMB – assembly biosciences, inc. (US:NASDAQ)
Stock Stats
News
Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026
Assembly Biosciences (ASMB) had its price target raised by Guggenheim from $39.00 to $43.00. They now have a "buy" rating on the stock.
Assembly Biosciences (ASMB) was upgraded by Wall Street Zen from "buy
Assembly Biosciences (ASMB) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights [Yahoo! Finance]
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: Bjorkquist Jeanette M
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: White Nicole S
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: Gaggar Anuj
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: Delaney William E IV
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: Okazaki Jason A
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.